サマリー

PD-1およびPD-L1阻害剤の世界市場2022-2026年
TechnavioはPD-1およびPD-L1阻害剤市場を監視しており、2022-2026年の間に493億4000万ドルの成長が見込まれ、予測期間中にCAGR 19.31%で加速しています。当レポートでは、PD-1およびPD-L1阻害剤市場の全体分析、市場規模と予測、動向、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析などを提供しています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。市場は、がんの有病率の増加、患者支援プログラムの存在、pd1およびpdl1阻害剤の高い標的親和性および特異性によって牽引されています。
PD-1およびPD-L1阻害剤の市場分析には、アプリケーションセグメントと地理的状況が含まれます。
TechnavioのPD-1およびPD-L1阻害剤市場は、以下のようにセグメント化されています。
アプリケーション別
- 固形癌
- 血液関連腫瘍
地域別
- 北米
- 欧州
- アジア
- その他の地域（ROW）
本調査では、今後数年間のPD-1およびPD-L1阻害剤市場の成長を促進する主要な理由の1つとして、強力なパイプラインを挙げています。また、PD-1およびPD-L1阻害剤の研究分野に対する戦略的提携と拡大が、市場の大きな需要につながるでしょう。
Technavioは、複数のソースからのデータを調査、合成、要約する方法で、主要パラメータの分析により、市場の詳細なイメージを提示します。PD-1およびPD-L1阻害剤市場に関する当レポートは、以下の分野を対象としています。
- PD-1およびPD-L1阻害剤の市場サイジング
- PD-1およびPD-L1阻害剤の市場予測
- PD-1およびPD-L1阻害剤市場の産業分析
Technavioの強力なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Akeso Inc、Alphamab Oncology、Amgen Inc、AstraZeneca Plc、BeiGene Ltd、Bristol Myers Squibb Co.、Chia Tai Tianqing Pharmaceutical Group Co.Ltd.、イーライリリー・アンド・カンパニー、F.ホフマン・ラ・ロシュ社、ギリアド・サイエンス社、グラクソ・スミスクライン社、イノベント・バイオロジクス社、江蘇恒隆製薬有限公司、Merck and Co.Ltd.、Merck and Co.Inc.、Merck KGaA、Novartis AG、Pfizer Inc.、Regeneron Pharmaceuticals Inc.、Sanofi、Shanghai Jhunsi Biosciences Ltd.の6社が含まれています。また、PD-1およびPD-L1阻害剤市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、来たるべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/pd1-and-pdl1-inhibitors-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Application
o 5.1 Market segments
o Exhibit 24: Chart on Application - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
o 5.2 Comparison by Application
o Exhibit 26: Chart on Comparison by Application
o Exhibit 27: Data Table on Comparison by Application
o 5.3 Solid tumors - Market size and forecast 2021-2026
o Exhibit 28: Chart on Solid tumors - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Solid tumors - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Solid tumors - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Solid tumors - Year-over-year growth 2021-2026 (%)
o 5.4 Blood-related tumors - Market size and forecast 2021-2026
o Exhibit 32: Chart on Blood-related tumors - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Blood-related tumors - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Blood-related tumors - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Blood-related tumors - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Application
o Exhibit 36: Market opportunity by Application ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share by geography 2021-2026 (%)
o Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 Canada - Market size and forecast 2021-2026
o Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.10 UK - Market size and forecast 2021-2026
o Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.11 France - Market size and forecast 2021-2026
o Exhibit 74: Chart on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on France - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on France - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity by geography
o Exhibit 78: Market opportunity by geography ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 Amgen Inc.
o Exhibit 85: Amgen Inc. - Overview
o Exhibit 86: Amgen Inc. - Product / Service
o Exhibit 87: Amgen Inc. - Key offerings
o 10.4 AstraZeneca Plc
o Exhibit 88: AstraZeneca Plc - Overview
o Exhibit 89: AstraZeneca Plc - Product / Service
o Exhibit 90: AstraZeneca Plc - Key news
o Exhibit 91: AstraZeneca Plc - Key offerings
o 10.5 BeiGene Ltd.
o Exhibit 92: BeiGene Ltd. - Overview
o Exhibit 93: BeiGene Ltd. - Business segments
o Exhibit 94: BeiGene Ltd. - Key offerings
o Exhibit 95: BeiGene Ltd. - Segment focus
o 10.6 Bristol Myers Squibb Co.
o Exhibit 96: Bristol Myers Squibb Co. - Overview
o Exhibit 97: Bristol Myers Squibb Co. - Product / Service
o Exhibit 98: Bristol Myers Squibb Co. - Key offerings
o 10.7 Eli Lilly and Co.
o Exhibit 99: Eli Lilly and Co. - Overview
o Exhibit 100: Eli Lilly and Co. - Product / Service
o Exhibit 101: Eli Lilly and Co. - Key offerings
o 10.8 F. Hoffmann La Roche Ltd.
o Exhibit 102: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 103: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 104: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 105: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 106: F. Hoffmann La Roche Ltd. - Segment focus
o 10.9 GlaxoSmithKline Plc
o Exhibit 107: GlaxoSmithKline Plc - Overview
o Exhibit 108: GlaxoSmithKline Plc - Business segments
o Exhibit 109: GlaxoSmithKline Plc - Key news
o Exhibit 110: GlaxoSmithKline Plc - Key offerings
o Exhibit 111: GlaxoSmithKline Plc - Segment focus
o 10.10 Merck and Co. Inc.
o Exhibit 112: Merck and Co. Inc. - Overview
o Exhibit 113: Merck and Co. Inc. - Business segments
o Exhibit 114: Merck and Co. Inc. - Key news
o Exhibit 115: Merck and Co. Inc. - Key offerings
o Exhibit 116: Merck and Co. Inc. - Segment focus
o 10.11 Merck KGaA
o Exhibit 117: Merck KGaA - Overview
o Exhibit 118: Merck KGaA - Business segments
o Exhibit 119: Merck KGaA - Key news
o Exhibit 120: Merck KGaA - Key offerings
o Exhibit 121: Merck KGaA - Segment focus
o 10.12 Sanofi
o Exhibit 122: Sanofi - Overview
o Exhibit 123: Sanofi - Business segments
o Exhibit 124: Sanofi - Key news
o Exhibit 125: Sanofi - Key offerings
o Exhibit 126: Sanofi - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 127: Inclusions checklist
o Exhibit 128: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 129: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 130: Research methodology
o Exhibit 131: Validation techniques employed for market sizing
o Exhibit 132: Information sources
o 11.5 List of abbreviations
o Exhibit 133: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Application - Market share 2021-2026 (%)
Exhibits25: Data Table on Application - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Application
Exhibits27: Data Table on Comparison by Application
Exhibits28: Chart on Solid tumors - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Solid tumors - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Solid tumors - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Solid tumors - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Blood-related tumors - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Blood-related tumors - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Blood-related tumors - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Blood-related tumors - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Application ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share by geography 2021-2026 (%)
Exhibits39: Data Table on Market share by geography 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity by geography ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Amgen Inc. - Overview
Exhibits86: Amgen Inc. - Product / Service
Exhibits87: Amgen Inc. - Key offerings
Exhibits88: AstraZeneca Plc - Overview
Exhibits89: AstraZeneca Plc - Product / Service
Exhibits90: AstraZeneca Plc - Key news
Exhibits91: AstraZeneca Plc - Key offerings
Exhibits92: BeiGene Ltd. - Overview
Exhibits93: BeiGene Ltd. - Business segments
Exhibits94: BeiGene Ltd. - Key offerings
Exhibits95: BeiGene Ltd. - Segment focus
Exhibits96: Bristol Myers Squibb Co. - Overview
Exhibits97: Bristol Myers Squibb Co. - Product / Service
Exhibits98: Bristol Myers Squibb Co. - Key offerings
Exhibits99: Eli Lilly and Co. - Overview
Exhibits100: Eli Lilly and Co. - Product / Service
Exhibits101: Eli Lilly and Co. - Key offerings
Exhibits102: F. Hoffmann La Roche Ltd. - Overview
Exhibits103: F. Hoffmann La Roche Ltd. - Business segments
Exhibits104: F. Hoffmann La Roche Ltd. - Key news
Exhibits105: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits106: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits107: GlaxoSmithKline Plc - Overview
Exhibits108: GlaxoSmithKline Plc - Business segments
Exhibits109: GlaxoSmithKline Plc - Key news
Exhibits110: GlaxoSmithKline Plc - Key offerings
Exhibits111: GlaxoSmithKline Plc - Segment focus
Exhibits112: Merck and Co. Inc. - Overview
Exhibits113: Merck and Co. Inc. - Business segments
Exhibits114: Merck and Co. Inc. - Key news
Exhibits115: Merck and Co. Inc. - Key offerings
Exhibits116: Merck and Co. Inc. - Segment focus
Exhibits117: Merck KGaA - Overview
Exhibits118: Merck KGaA - Business segments
Exhibits119: Merck KGaA - Key news
Exhibits120: Merck KGaA - Key offerings
Exhibits121: Merck KGaA - Segment focus
Exhibits122: Sanofi - Overview
Exhibits123: Sanofi - Business segments
Exhibits124: Sanofi - Key news
Exhibits125: Sanofi - Key offerings
Exhibits126: Sanofi - Segment focus
Exhibits127: Inclusions checklist
Exhibits128: Exclusions checklist
Exhibits129: Currency conversion rates for US$
Exhibits130: Research methodology
Exhibits131: Validation techniques employed for market sizing
Exhibits132: Information sources
Exhibits133: List of abbreviations